Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.
Goldman Unit Buys €2 Billion Drugmaker Synthon From BC Partners
Estimated read time
1 min read
You May Also Like
Did Japan Intervene to Prop Up the Yen? How We Might Know
December 25, 2024
Oil Gains in Thin Pre-Holiday Trading With Focus on China, Trump
December 25, 2024
Gold Steadies as Traders Focus on Uncertain 2025 Rate Path
December 25, 2024
More From Author
2025’s Crypto Millionaire Makers: 5 Coins With 10,000%+ Potential
December 25, 2024
Did Japan Intervene to Prop Up the Yen? How We Might Know
December 25, 2024
Memecoins take top spot for crypto investor interest in 2024: CoinGecko
December 25, 2024
+ There are no comments
Add yours